Makers Laboratories

Price chart

Previous close

₹223.62

Open

₹222.51

Day high

₹259.00

Day low

₹222.51

Listed on NSE since 17 August 2026.

Market value

₹149.41 Cr

P/E (trailing)

45.46

EPS (trailing)

₹5.57

Price to book

2.05

Dividend yield

0.00%

Debt to equity

0.05

Profit margin

2.3%

Beta

0.17

Volume today

56,092

Average volume

8,316

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results are unavailable from NSE right now, or none are on file for this company.

The balance sheet is unavailable from NSE right now, or none is on file for this company.

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company also exports its products. Makers Laboratories Limited was incorporated in 1984 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

114

Company website · Profile: Yahoo Finance

No headlines name Makers Laboratories in the last day or two.

NSE lists no dividends or other corporate actions for Makers Laboratories.